BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26515215)

  • 21. [Development and response to intravenous treatment with tissue plasminogen activator with regard to referral hospitals. The experience of a stroke referral unit].
    Romero-Sevilla RM; Portilla-Cuenca JC; Falcon-Garcia A; Calle-Escobar ML; Serrano-Cabrera A; Gámez-Leyva G; González-Soltero ME; Gómez M; Jiménez-Caballero PE; Casado-Naranjo I
    Rev Neurol; 2012 Feb; 54(4):209-13. PubMed ID: 22314761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis.
    Strbian D; Sairanen T; Rantanen K; Piironen K; Atula S; Tatlisumak T; Soinne L;
    Cerebrovasc Dis; 2011; 31(1):37-42. PubMed ID: 20980752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between Dysphagia, National Institutes of Health Stroke Scale Score, and Predictors of Pneumonia after Ischemic Stroke.
    Ribeiro PW; Cola PC; Gatto AR; da Silva RG; Luvizutto GJ; Braga GP; Schelp AO; de Arruda Henry MA; Bazan R
    J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):2088-94. PubMed ID: 26187787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.
    Kim DH; Cha JK; Park HS; Choi JH; Kang MJ; Huh JT
    J Clin Neurosci; 2014 Aug; 21(8):1428-32. PubMed ID: 24980628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Leukoaraiosis Burden on Hemispheric Lateralization of the National Institutes of Health Stroke Scale Deficit in Acute Ischemic Stroke.
    Helenius J; Goddeau RP; Moonis M; Henninger N
    Stroke; 2016 Jan; 47(1):24-30. PubMed ID: 26556825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percent change on the National Institutes of Health Stroke Scale: a useful acute stroke outcome measure.
    Bruno A; Saha C; Williams LS
    J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):56-9. PubMed ID: 19110146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of the Cincinnati Prehospital Stroke Scale for identifying thrombolytic candidates in acute ischemic stroke.
    You JS; Chung SP; Chung HS; Lee HS; Park JW; Kim HJ; Lee SH; Park I; Lee HS
    Am J Emerg Med; 2013 Dec; 31(12):1699-702. PubMed ID: 24055479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolysis for Acute Minor Stroke: Outcome and Barriers to Management. Results from the RESUVAL Stroke Network.
    Laurencin C; Philippeau F; Blanc-Lasserre K; Vallet AE; Cakmak S; Mechtouff L; Cho TH; Ritzenthaler T; Flocard E; Bischoff M; El Khoury C; Nighoghossian N; Derex L
    Cerebrovasc Dis; 2015; 40(1-2):3-9. PubMed ID: 25998791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Missing Stroke Severity Data on the Accuracy of Hospital Ischemic Stroke Mortality Profiling.
    Thompson MP; Luo Z; Gardiner J; Burke JF; Nickles A; Reeves MJ
    Circ Cardiovasc Qual Outcomes; 2018 Oct; 11(10):e004951. PubMed ID: 30354572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National Institutes of Health Stroke Scale (NIHSS) as An Early Predictor of Poststroke Dysphagia.
    Jeyaseelan RD; Vargo MM; Chae J
    PM R; 2015 Jun; 7(6):593-8. PubMed ID: 25556573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
    Lin CB; Peterson ED; Smith EE; Saver JL; Liang L; Xian Y; Olson DM; Shah BR; Hernandez AF; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):514-22. PubMed ID: 22787065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes after intravenous fibrinolysis in cryptogenic strokes with or without patent foramen ovale.
    Chang JJ; Chiem T; Alderazi YJ; Chapple K; Restrepo L
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e492-9. PubMed ID: 23871701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries.
    Sakamoto Y; Koga M; Kimura K; Nagatsuka K; Okuda S; Kario K; Hasegawa Y; Okada Y; Yamagami H; Furui E; Nakagawara J; Shiokawa Y; Okata T; Kobayashi J; Tanaka E; Minematsu K; Toyoda K
    Eur J Neurol; 2014 Mar; 21(3):419-26. PubMed ID: 24261412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy.
    Takagi T; Kato T; Sakai H; Nishimura Y
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):69-74. PubMed ID: 23164483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The types of neurological deficits might not justify withholding treatment in patients with low total National Institutes of Health Stroke Scale scores.
    Leira EC; Ludwig BR; Gurol ME; Torner JC; Adams HP
    Stroke; 2012 Mar; 43(3):782-6. PubMed ID: 22308246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive ability of C-reactive protein for early mortality after ischemic stroke: comparison with NIHSS score.
    Ghabaee M; Zandieh A; Mohebbi S; Fakhri M; Sadeghian H; Divani F; Amirifard H; Mousavi-Mirkala M; Ghaffarpour M
    Acta Neurol Belg; 2014 Mar; 114(1):41-5. PubMed ID: 23975559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.